KEVIN KOTLER

Insider Reports History

Location
New York, NY
Signature
/s/ Lisa Peraza Attorney-in-fact for Kevin Kotler
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by KEVIN KOTLER:

Company Role Class Num Shares Value Price $ Report Date Ownership
HERON THERAPEUTICS, INC. /DE/ Director Common Stock 540,000 $1,161,000 $2.15 22 Feb 2023 By Broadfin Holdings LLC
HERON THERAPEUTICS, INC. /DE/ Director Common Stock 37,879 $81,440 $2.15 22 Feb 2023 Direct
BIODELIVERY SCIENCES INTERNATIONAL INC Director Common Stock 0 $1.80 22 Mar 2022 Indirect
BIODELIVERY SCIENCES INTERNATIONAL INC Director Restricted Stock Units 0 22 Mar 2022 Indirect
BIODELIVERY SCIENCES INTERNATIONAL INC Director Series B Convertible Preferred Stock 0 11 Feb 2022 Indirect
BIODELIVERY SCIENCES INTERNATIONAL INC Director Stock Options (right to buy) 0 $3.66 22 Mar 2022 Indirect

Insider Reports Filed by KEVIN KOTLER